Regeneron Pharmaceuticals (REGN)
(Real Time Quote from BATS)
$1,061.92 USD
+6.35 (0.60%)
Updated Jul 24, 2024 01:26 PM ET
4-Sell of 5 4
D Value D Growth F Momentum F VGM
Earnings News For REGN
-
Regeneron (REGN) to Report Q2 Earnings: What's in the Cards?
-
IN BRIEF: Regeneron says second quarter results to include R&D charge
-
Regeneron (REGN) Q1 Earnings, Sales Miss on Lower Eylea Sales
-
Regeneron: Q1 Earnings Snapshot
-
Regeneron Reports First Quarter 2024 Financial and Operating Results
-
Regeneron (REGN) Reports Next Week: What You Should Expect
-
Regeneron (REGN) Gets FDA Nod for Praluent Label Extension
-
Regeneron (REGN) Q4 Earnings & Sales Top, Eylea Sales Decline
-
Regeneron: Q4 Earnings Snapshot
-
Regeneron (REGN) Q4 Earnings and Revenues Top Estimates
-
Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results
-
Regeneron (REGN) to Report Q4 Earnings: What's in the Cards?
-
Earnings Preview: Regeneron (REGN) Q4 Earnings Expected to Decline
-
Regeneron (REGN) Q3 Earnings & Sales Top, Eylea Sales Decline
-
Regeneron: Q3 Earnings Snapshot
-
Regeneron Reports Third Quarter 2023 Financial and Operating Results
-
Regeneron (REGN) to Report Q3 Earnings: What's in the Cards?
-
Analysts Estimate Regeneron (REGN) to Report a Decline in Earnings: What to Look Out for
-
Regeneron (REGN) Q2 Earnings & Sales Top, Eylea Sales Decline
-
Regeneron (REGN) Tops Q2 Earnings and Revenue Estimates
-
Regeneron Reports Second Quarter 2023 Financial and Operating Results
-
Regeneron (REGN) to Report Q2 Earnings: What's in Store?
-
Regeneron (REGN) Q1 Earnings & Sales Top, Eylea Sales Decline
-
Regeneron (REGN) Q1 Earnings and Revenues Top Estimates
-
Regeneron: Q1 Earnings Snapshot